We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Looking Into Multaq, Actos for Potential Safety Concerns
FDA Looking Into Multaq, Actos for Potential Safety Concerns
February 4, 2011
The FDA is raising new safety concerns about several drugs including Sanofi-Aventis’ heart medication Multaq and Takeda’s blockbuster diabetes drug Actos.